Merck & Co., Inc. Debt Instrument, Face Amount
Merck & Co., Inc. (MRK) had Debt Instrument, Face Amount of $8.00 billion as of 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2022-02-25
- 2016-11-30: Debt Instrument, Face Amount 1.00B EUR.
- 2014-10-31: Debt Instrument, Face Amount 2.50B EUR.
EUR
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2016-11-30 | 1.00B EUR 10-K · filed 2017-02-28 |
| 2014-10-31 | 2.50B EUR 10-K · filed 2017-02-28 |
USD
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2021-12-31 | $8.00B 10-K · filed 2022-02-25 |
| 2020-06-30 | $4.50B 10-K · filed 2021-02-25 |
| 2019-03-31 | $5.00B 10-K · filed 2020-02-26 |
| 2015-02-28 | $8.00B 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |